CrushSCI.com
138.6Average days
131.5Median days
26Fastest days
282Longest days
1412025 publications

Paper Review Records

All Paper Review Records

30 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

229 days

Blocking aryl hydrocarbon receptor remodels myeloid–T cell crosstalk and enhances anti-PD-1 response in the tumor microenvironment

Authors
Dong Kwon Kim; Sujeong Baek; Youngtaek Kim; Seung Min Yang; So Young Park; Su Jin Choi; Ju Hyeon Lee; Sang Hoon Lee; Jongho Cho; Daewon Cha; Dajeong Kim; Sunghwa Kim; Jae Hwan Kim; Byoung Chul ChoShow moreShow less
Affiliations
1. Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea; 2. Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea; 3. Yonsei New Il Han Institute for Integrative Lung Cancer Research, Yonsei University College of Medicine, Seoul, Korea; 4. Dong-A ST Research Institute, Yongin-si, Korea; 5. Division of Medical Oncology, Department of Internal Medicine, Severance Hospital, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, KoreaShow moreShow less
Source PDF DOI Publisher page
40 days

Oncogenic RAS as an adaptive signaling ecosystem: context-dependent vulnerabilities and resistance-informed therapeutic design

Authors
Amir Abbas Hamidi; Omeed Moaven; Reihaneh Alsadat Mahmoudian; Mohammad Reza AbbaszadeganShow moreShow less
Affiliations
1. Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; 2. Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; 3. Division of Surgical Oncology, Department of Surgery, LSU Health New Orleans School of Medicine, New Orleans, USA; 4. LSU LCMC Health Cancer Center, New Orleans, USA; 5. Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, IranShow moreShow less
Source PDF DOI Publisher page
92 days

Innovations and emerging trends in adoptive cell therapies for solid tumors: engineering strategies and clinical translation

Authors
Peng Huang; WenLin Wu; Yu Min; Yi Zhang; YunFeng Tao; Zheran Liu; Zhigong Wei; Xingchen PengShow moreShow less
Affiliations
1. Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, P.R. China; 2. Nuclear Physics and Medical Research Key Laboratory of Sichuan Province, Sichuan University, Chengdu, P.R. ChinaShow moreShow less
Source PDF DOI Publisher page
186 days

Cobimetinib impairs tumor survival and immune escape by altering my-CAFs in BRAFV600E-mutated anaplastic thyroid carcinoma

Authors
Mario Udinotti; Niclas Ramm; Thamer Abed Alhaleem Amin Hamdan; Muhammad Sameer Ali Khan; Udo Siebolts; Marcus Bauer; Kerstin Lorenz; Christine Dierks; Claudia Wickenhauser; Barbara SeligerShow moreShow less
Affiliations
1. Institute of Pathology, Section Immunopathology, Martin Luther University Halle-Wittenberg, Halle, Germany; 2. Institute of Tumor Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany; 3. Institute of Pathology, University Hospital, Cologne, Germany; 4. Department of Visceral, Vascular and Endocrine Surgery, Martin Luther University Halle-Wittenberg, Halle, Germany; 5. Department of Hematology/Oncology and Stem Cell Transplantation, KIM IV, Martin-Luther University Halle-Wittenberg, Halle, Germany; 6. Department of Hematology and Oncology, Freiburg University Medical Center, Albert-Ludwigs-University of Freiburg, Breisgau, Germany; 7. Institute of Translational Immunology, Center for Translational Medicine, Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Brandenburg, Germany; 8. Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, GermanyShow moreShow less
Source PDF DOI Publisher page
186 days

Dysregulated KMT2D mutant targeting immunogenic rewiring to overcome epigenetic entropy promotes follicular lymphomagenesis

Authors
Yuqian Zhu; Jingwei Yao; Yuelong Jiang; Qian Lai; Qinwei Chen; Jingxing Zhang; Manman Deng; Zhijuan Lin; Yiming Luo; Zhifeng Li; Long Liu; Zhong Zheng; Jie Zha; Bing XuShow moreShow less
Affiliations
1. Department of Hematology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China; 2. Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China; 3. Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShow moreShow less
Source PDF DOI Publisher page
199 days

Multimodal AI and single-cell transcriptomics integrate to construct a histopathological prognostic model for bladder cancer, revealing the RTN3-glycolysis axis in chemoresistance

Authors
Shunli Yu; Yingjian Wang; Dapeng Feng; Xinglai Dai; Yongbo Luo; Jianing Wang; Zihe Wang; Fuxiang Chen; Haoran Wang; Fengyan Tian; Xuejia Zhai; Chaohui GuShow moreShow less
Affiliations
1. Department of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 2. Department of Endocrinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 3. Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 4. Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, ChinaShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.